SCHEMBL9683712

SCHEMBL9683712

C[C@@H](CCc1ccc(C(N)=O)s1)N(C[C@H](O)COc1ccccc1)[C@H](O)Cc1cccc(C(F)(F)F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 2/20 0.40
ABCB1 P08183 3/20 0.38
MAOB P27338 1/20 0.37
NR1H3 Q13133 1/20 0.36
PPARG P37231 1/20 0.36
PPARA Q07869 1/20 0.36
EPHX1 P07099 1/20 0.36
NR1I2 O75469 1/20 0.35
ADRB1 P08588 1/20 0.35
HTR1A P08908 1/20 0.35
ADRA2A P08913 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35
CHRM3 P20309 1/20 0.35
SLC6A2 P23975 1/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
SLC6A4 P31645 1/20 0.35
ADRA1A P35348 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9683745 0.90 ABCB1 (0.44) ABCB1ADRB1CYP1A2CYP2D6CYP2C9
SCHEMBL9684099 0.78 ABCB1 (0.42) ABCB1ADRB1CYP1A2CYP2D6CYP2C9
SCHEMBL9684091 0.78 ABCB1 (0.42) ABCB1ADRB1CYP1A2CYP2D6CYP2C9
SCHEMBL9683706 0.75 NR1H3 (0.35) ABCB1MAOBNR1H3ADRB1
SCHEMBL9811916 0.74 ABCB1 (0.54) ABCB1CYP1A2CYP2D6CYP2C9
SCHEMBL9787435 0.73 ABCB1 (0.46) ABCB1ADRB1CYP2D6
SCHEMBL9787439 0.73 ABCB1 (0.46) ABCB1ADRB1CYP2D6
SCHEMBL10822430 0.72 PNMT (0.43) PTGER4EPHX1
SCHEMBL10822433 0.72 PNMT (0.43) PTGER4EPHX1
SCHEMBL9683741 0.71 ABCB1 (0.36) ABCB1ADRB1KCNH2CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5166218-A Antilipemic agents or antiglycemic agents HOFFMANN-LA ROCHE INC. (US) 1992-11-24 US disclosed
US-5064863-A Catabolic activity, obesity, diabetes HOFFMANN-LA ROCHE INC. (US) 1991-11-12 US disclosed